Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in lab studies, though long-term safety in humans remains unknown.

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune | Cancer ...

DOC1021 is a first-in-class, patient-derived double-loaded dendritic cell therapy that combines tumor lysate and amplified tumor-derived mRNA. The immunotherapy is made with a patient's dendritic ...

Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced four strategic additions to its executive leadership team: Jeff ...

Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta ...

CLEVELAND, Ohio — A shift toward personalized treatment for breast cancer, ways to help patients live longer without their cancer worsening and a shorter but equally effective treatment for a ...

The Medal of Honor is presented to individuals whose research has fundamentally advanced cancer prevention, diagnosis, treatment, and survivorship.

The treatment is known as 3D interstitial high-dose-rate brachytherapy, a technique that delivers radiation directly inside the tumour rather than from outside the body.

Over the last two years, research has improved the understanding and treatment of disease. Using tools such as gene editing, ...